论文部分内容阅读
我们自1990年以来,用肝素治疗冠心病心绞痛26例,取得了较好的疗效,现报告如下: 1 临床资料 1.1 病例选择 本组观察对象均按1979年《冠心病诊断标准》诊断的冠心病心绞痛病人。26例中劳力型心绞痛病人9例,变异型心绞痛10例,自发型心绞痛7例。其中男16例,女10例,年龄44～71岁,平均年龄54.8岁。本组病例治疗前后均做静息心电图、凝血时间测定及血、尿常规。另选23例心绞痛患者为对照组,平均年龄57.2岁,行常规心得安治疗(每日三次,每次10mg)。 1.2 药物用法 苏州生化制药厂生产的肝素钙4000单位作皮下注射,每8小时1次,疗程为20天。
We have used since 2000, 26 cases of coronary heart disease angina pectoris, and achieved good results, are as follows: 1 clinical data 1.1 case selection in this group of observers were diagnosed in accordance with the “diagnostic criteria for coronary heart disease in 1979,” the diagnosis of coronary heart disease Angina patients. 26 cases of labor-type angina patients in 9 cases, 10 cases of variant angina, spontaneous angina in 7 cases. Including 16 males and 10 females, aged 44 to 71 years, with an average age of 54.8 years. The patients before and after treatment were done resting electrocardiogram, coagulation time and blood, urine routine. Another 23 patients with angina pectoris as control group, mean age 57.2 years old, routine treatment of Andean (three times a day, each 10mg). 1.2 drug usage Suzhou Biochemical Pharmaceutical Factory production of heparin 4000 units for subcutaneous injection, every 8 hours 1, course of treatment for 20 days.